Nestlé Joins the Microbiome Therapeutics Innovation Group (MTIG); Krys Araujo-Torres, MD, MPP to Represent Company [Yahoo! Finance]
Seres Therapeutics, Inc. (MCRB)
Last seres therapeutics, inc. earnings: 11/5 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.serestherapeutics.com
Company Research
Source: Yahoo! Finance
independent coalition advancing FDA-approved microbiome therapeutics and microbiome-based products. MTIG works to enhance the regulatory, investment, and commercial environment to accelerate development and expand patient access to life-changing microbiome medicines. Nestlé Health Science Logo (PRNewsfoto/Nestlé Health Science U.S.) As part of Nestlé's participation, Krys Araujo-Torres, MD, MPP, Global Head of Medical, Science, Regulatory Organization (MSRO), Nestlé Health Science, will serve as Nestlé's primary representative within MTIG. "Joining Microbiome Therapeutics Innovation Group reflects our commitment to responsible, science-led advancement of microbiome therapeutics," said Luis Briz, President, Professional Health, Nestlé Health Science. "Together with fellow members, we'll champion clear, pragmatic pathways that help bring safe, effective microbiome medicines to more patients." "VOWST established an important clinical and regulatory precedent as the first oral liv
Show less
Read more
Impact Snapshot
Event Time:
MCRB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MCRB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MCRB alerts
High impacting Seres Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
MCRB
News
- Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026GlobeNewswire
- Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026GlobeNewswire
- Seres Therapeutics to Present at CARB-X Investor DayGlobeNewswire
- Seres Therapeutics (MCRB) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $22.00 price target on the stock.MarketBeat
- Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdatesGlobeNewswire
MCRB
Earnings
- 3/12/26 - Beat
MCRB
Analyst Actions
- 3/13/26 - Canaccord Genuity
MCRB
Sec Filings
- 4/27/26 - Form DEFA14A
- 4/27/26 - Form DEF
- 3/17/26 - Form 144
- MCRB's page on the SEC website